RxDoctor Payments Data

Troy Gingerich, MD

Interventional Pain Medicine · Charlotte, NCNPI 1104007319

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $15,215 of the $18,553 with a category attached, or 82.0%. 13 manufacturers reported payments, led by SPR Therapeutics, Inc at 35.9% of the total.

$18,553in general payments, 2019–2025

Across 297 payments — averaging $62.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SPR Therapeutics, Inc$7K
  • Nevro Corp.$4K
  • Boston Scientific$3K
  • Medtronic$1K
  • Vertiflex, Inc.$1K
  • Globus Medical$921
  • plus $1K from 7 others

What the payments were for

  • Consulting fees$2,70015%
  • Travel & lodging$6373%
  • Food & beverage$15,21582%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,553 in reported general payments places this provider in the 80th percentile of 45 interventional pain medicine providers in North Carolina.

See all interventional pain medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$86,089
Medicare patients
301
Services billed
1,095

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PercocetOxycodone Hcl/Acetaminophen11$49,076
NucyntaTapentadol Hcl13$21,632
Xtampza ErOxycodone Myristate33$19,278
Levorphanol Tartrate11$18,098
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen583$16,211
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen622$13,881
MovantikNaloxegol Oxalate28$13,241
OxycontinOxycodone Hcl20$11,198
Oxycodone Hcl234$5,034
Fentanyl37$3,567
Gabapentin176$3,172
Lubiprostone14$2,019
Tizanidine Hcl139$1,800
Tramadol Hcl ErTramadol Hcl28$1,655
Tramadol Hcl177$1,577

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →